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Heterotrimeric G protein complexes are conserved from
plants to mammals, but the complexity of each system varies.
Arabidopsis thaliana contains one G, one G (AGB1), and at
least three G subunits, allowing it to form three versions of the
heterotrimer. This plant model is ideal for genetic studies
because mammalian systems contain hundreds of unique het-
erotrimers. The activation of these complexes promotes inter-
actions between both the G subunit and the G dimer with
enzymes and scaffolds to propagate signaling to the cytoplasm.
However, although effectors of G and G are known in mam-
mals, no G effectors were previously known in plants. Toward
identifying AGB1 effectors, we genetically screened for domi-
nant mutations that suppress G-null mutant (agb1-2) pheno-
types. We found that overexpression of acireductone dioxyge-
nase 1 (ARD1) suppresses the 2-day-old etiolated phenotype of
agb1-2. ARD1 is homologous to prokaryotic and eukaryotic
ARD proteins; one function of ARDs is to operate in the methi-
onine salvage pathway. We show here that ARD1 is an active
metalloenzyme, and AGB1 and ARD1 both control embryonic
hypocotyl length bymodulating cell division; they alsomay con-
tribute to the production of ethylene, a product of the methio-
nine salvage pathway. ARD1 physically interacts with AGB1,
and ARD enzymatic activity is stimulated by AGB1 in vitro. The
binding interface on AGB1 was deduced using a comparative
evolutionary approach and tested using recombinant AGB1
mutants. A possible mechanism for AGB1 activation of ARD1
activity was tested using directed mutations in a loop near the
substrate-binding site.
One way that cells communicate with one another and per-
ceive and respond to both intercellular and extracellular signals
is through heterotrimeric guanine nucleotide-binding protein
(G protein) signaling. As known for animal cells, G protein sig-
naling begins when an extracellular ligand binds to a seven-
transmembrane receptor that is physically coupled to an inac-
tive heterotrimeric complex consisting of G-GDP, G, and
G subunits located on the cytoplasmic side of the cell mem-
brane. Upon activation by the receptor, the G exchanges GDP
forGTP and dissociates from the receptor and the obligateG
dimer, allowing free G and free G to participate in down-
stream signaling processes through concomitant interactions
with proteins called effectors. This signaling ceases when G
hydrolyzes GTP to GDP and the heterotrimer reforms (1, 2).
Mammalian species possess a complex array of possible G pro-
tein heterotrimer combinations as there are 16 G, 5 G, and
12 G genes, making genetic studies difficult. However, the
Arabidopsis thaliana genome encodes one G (GPA1), one G
(AGB1), and three G (AGG1, AGG2, and AGG3) genes (3)
and thus three heterotrimeric combinations (2). As a result, all
G protein signaling in Arabidopsis can be abolished by mutat-
ing only a few genes, making this an ideal genetic model for
G protein signaling in a multicellular context. Additionally,
because there is high similarity between the G protein compo-
nents of plants and metazoans, findings from Arabidopsis are
applicable to signaling in humans.
Arabidopsis plants lacking AGB1 mRNA transcript (agb1-2)
have a wide array of developmental phenotypes.Mature agb1-2
plants display aberrant leaf shape, silique morphology, and
increased root mass (4) and are hypersensitive to infection by
the necrotrophic pathogens Plectosphaerella cucumerina and
Fusariumoxysporum (5, 6). Two-day-old etiolatedagb1-2 seed-
lings have a shorter, thicker hypocotyl and a more open apical
hook thanwild type seedlings (4, 7). The shortened hypocotyl in
agb1-2 seedlings is due to fewer cells (4, 7) and therefore a
decrease in cell division. The apical hook morphology is con-
trolled by a number of factors, including the hormone ethylene.
Increased ethylene production is one factor that promotes the
closure of the apical hook (8).
Although we previously identified proteins that interact
genetically (SGB1 (9)) and physically (NDL1 (10)) with AGB1,
to date no AGB1 effectors (i.e. proteins whose activities are
regulated by AGB1) have been identified in plants. This is in
stark contrast to the wide array of studies regarding mamma-
lian G signaling; in mammals, many G effectors have been
identified, including adenylyl cyclase 2 (AC2), phospholipase C
2 (PLC-2), and cation channels (11). However, no protein
that interacts with AGB1 in plants has been shown to play a
direct role in the modulation of cell division (12). To identify
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potential effectors in the AGB1 signaling pathway, we utilized
an activation tagging approach to randomly create dominant
suppressors of agb1-2 (13). Specifically, we screened genes
whose increased expressionwould restore the cell division phe-
notype displayed in the 2-day-old etiolated agb1-2 hypocotyl
(9).
EXPERIMENAL PROCEDURES
Screen for Suppressors of agb1-2 and Plasmid Rescue— sgb3-1D
was identified in the activation tagging suppressor screen that
was described previously by Wang et al. (9).
Plant Materials—All Arabidopsis seeds were in the Colum-
bia-0 ecotype. The following tDNA insertion mutant alleles
were used: ard1-1 (SALK_119327), ard1-2 (GABI_595C04)
(14), and ard1-3 (SALK_034308). tDNA insertions were con-
firmed by full-length genotyping PCR using primers listed in
supplemental Table S1. mRNA transcript levels were identified
by RT-PCR. Total RNA was isolated from rosette leaves using
theRNeasyTMplantmini kit (Qiagen,Valencia, CA), and cDNA
synthesis was performed using a poly(dT) primer. RT-PCR was
performedwith the SuperScript III RT-PCRTM kit (Invitrogen).
PCR was performed for 25 cycles (94 °C for 30 s, 55 °C for 30 s,
and 72 °C for 1 min) using the primers listed in supplemental
Table S1. agb1-2 has been described previously (4).Gene
accession numbers are as follows: AGB1, At4g34460; ARD1,
At4g14716; ARD2, At4g14710; ARD3, At2g24600; ARD4,
At5g43850.
Hypocotyl and Hook Assays and Epidermal Cell Counting—
Seeds were sterilized in 70% ethanol for 1 min and 30% bleach
plus 0.01% Tween 20 for 20 min and rinsed 3–5 times with
sterile distilled water. Seeds were sown on square Petri plates
containing 1⁄2 Murashige and Skoog (MS) salts, 1% sucrose,
and 0.6% phytagel. The plates were incubated at 4 °C in the dark
for 2–4 days, exposed to light for 2 h, and grown vertically in the
dark for 2 days (52 h) or 4 days at 22 °C. Upon opening, the
plates were immediately scanned and imaged. Apical hook
angles and hypocotyl lengthswere quantified using ImageJ soft-
ware. For epidermal cell counting, 52 h seedlings were incu-
bated overnight in a solution of 8:2:1 chloral hydrate (1mg/ml),
glycerol, and water. Epidermal cells were imaged using Nomar-
ski optics as described previously (7).
Stomatal Index—Seven-day-old seedlings were stained with
1 mg/ml propidium iodide for 15 min and rinsed briefly with
distilled water before visualization under a laser confocal scan-
ning microscope (Zeiss 710). Stomatal index (SI)2 was calcu-
lated using the following equation: SI  number of stomata/
(number of stomata  number of pavement cells). SI was
calculated for each cotyledon individually, and the means 
S.D. were calculated from five cotyledons from five seedlings.
Ethylene Biosynthesis—Seeds were sterilized as reported
above and sown in a 0.06% agarose suspension in 22-ml gas
chromatography vials containing 3 ml of 1 MS salts, 1%
sucrose, and 0.6% agar. 100–200 seeds were sown for ethylene
measurements at 2 days. The vials were placed at 4 °C in the
dark for 2–4 days for seed stratification, exposed to light for 2 h
at 22 °C, and then capped and grown in the dark at 22 °C for 2
days. Ethylene was measured by gas chromatography as
described previously (15). At least three vials weremeasured for
each genotype. The experiment was repeated once.
Statistics—Statistical analyses for the plant growth measure-
ments were performed using a type three two-tailed Student’s t
test.
Phylogenies and Bioinformatics—Representative ARD se-
quences were collected via a BLAST analysis across the species
indicated using ARD1 as a query. The alignment was generated
using ClustalX (16). MrBayes (17) was run using a fixed equalin
model, using the inverse  rate, and sampling 1,000,000 gener-
ations at a frequency of 100 for three independent runs with a
burn in of 250,000 generations to generate a consensus phylo-
genetic tree.
Modeling—A homology model of ARD1 was created using
MmADI1 (PDB code 1VR3); this structure was identified by a
BLAST search and chosen for its high sequence similarity. The
model was created using the Insight II software program from
Accelrys, Inc. (San Diego). The homology model was evaluated
with the Verify three-dimensional function of Insight II, and
the resulting normalized score was 0.74, indicating a viable
structure.
ARD1-GFP Transient Expression in Arabidopsis Protoplasts—
The coding region of ARD1was cloned into the YFP expression
vector pDH51. Arabidopsismesophyll protoplasts were gener-
ated from wild type and agb1-2 plants as described previously
(18). Cells were imaged using a Zeiss LSM 710 confocal laser
scanningmicroscope equippedwith a C-Apochromat X40 (NA
1.2) water immersion objective and standard Zeiss software
(ZEN).
Yeast Three-hybrid (Y3H) Protein Interaction—AGB1 and
AGG1 were cloned into the pBridgeTM vector (Clontech).
ARD1 was cloned into the p-ENTR/D-TOPOTM vector (Invit-
rogen) and then recombined into the pACTGW-attR Gateway
vector that contains an activation domain and is compatible
with the pBridgeTM vector. The bait (AGB1-AGG1) and prey
(ARD1) were transformed separately or together into yeast
strain AH109. All three strains (bait alone, prey alone, or bait
and prey) were grown on nutritionally selective media. The
presence of the bait and prey was confirmed by the expression
of nutritional markers (positive growth on media lacking tryp-
tophan and leucine, respectively). Interactionwas confirmed by
the expression of an additional nutritional marker (positive
growth on media lacking histidine). For Y3H experiments
involving AGB1 mutants, the coding sequence of wild type
AGB1 and of each mutant was cloned into the pAS vector,
which is compatible with the ARD1-pACTGW-attr vector.
Protein Expression (ARDs and AGB1 Used for Pulldowns and
Enzymatic Assays)—The coding regions of ARD1–4 were
cloned into pDEST17TM and pDEST15TM (Invitrogen) con-
taining an N-terminal poly-His tag and anN-terminal GST tag,
respectively, and were expressed in BL21-RosettaTM Esche-
richia coli cells. Protein expressionwas induced atOD 0.6 for
2 h at 37 °C. ARD-His was purified on a Talon column (Clon-
tech). ARD-GST was purified on an immobilized glutathione
2 The abbreviations used are: SI, stomatal index; ARD, acireductone dioxyge-
nase; AdoMet, S-adenosylmethionine; MTA, S-methylthioadenosine;
BLAST, basic local alignment search tool; Y3H, yeast-three hybrid; BiFC,
bimolecular fluorescence complementation; PDB, Protein Data Bank.
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column (Pierce). Protein concentrations were determined
using the Coomassie PlusTM reagent (Pierce). To purify G
protein from insect cells, AGB1 was cloned into pDEST8
(untagged vector), and AGG1 containing a C-terminal muta-
tion of the CAAX (where A is any aliphatic amino acid and X is
any amino acid) box prenylation site (C95*) was cloned into
pDEST10TM (N-terminal His6 tag) (Invitrogen). Baculoviruses
against each protein were generated and propagated using the
Bac-to-BacTM baculovirus expression system (Invitrogen).
Viruses were propagated separately in Sf9 cells, co-expressed in
Hi-5 cells, and purified on a TalonTM column (Clontech), and
concentrations were determined as described above.
AGB1 Polyclonal Antibody—A peptide consisting of 18
N-terminal residues (Thr-14 to Leu-31) of AGB1 was synthe-
sized and conjugated to the keyhole limpet hemocyanin. This
peptide carrier was used to raise an antibody in rabbits (Open
Biosystems, Huntsville, AL). In total, five immunizations were
administered. The terminal serum was incubated at a dilution
of 1:20,000 in phosphate-buffered saline containing 5% pow-
dered milk and 0.01% Tween 20 for 2 h to detect purified
proteins. The antiserum lot used here was designated
AGB1–1607-Ext.
Co-purification via Affinity Pulldown—Bacterial cells ex-
pressing a GST-tagged ARD protein (ARD1–4) were lysed
(sonicated in 25mMNaP, 300mMNaCl, 0.2 mM PMSF, and 1
protease inhibitor mixture (Sigma)) and then incubated with
glutathione beads. After washing, purified AGB1-AGG1 pro-
tein was added to the ARD bead mixture. After incubation, the
slurry was washed several times, and the protein complexes
were eluted from the beads by boiling in SDS loading buffer. A
subset of the elution product was run on an SDS-polyacryl-
amide gel. The proteins were transferred to a nitrocellulose
membrane and probed with the polyclonal AGB1 antibody
described above.
Bimolecular Fluorescence Complementation (BiFC)—BiFC
was performed according to Grigston et al. (19) with several
modifications. The coding sequences of ARD1, ARD2, ARD3,
ARD4, and AHP2 were cloned into the BiFC vectors
pCL112_JO (YFP-n) and pCL113_JO (YFP-c). The coding
sequence of AGB1 was cloned into pBatL-sYFP-C (YFP-c).
Constructs were co-infiltrated with mitochondrial red fluores-
cent protein (mt-Rk obtained from the Arabidopsis Biological
Resource Center, CD3-991) as a positive transformation con-
trol. Samples were imaged using a Zeiss LSM 710 confocal laser
scanningmicroscope equippedwith a C-Apochromat X40 (NA
1.2) water immersion objective and standard Zeiss software
(ZEN). Visualization of YFPwas achieved using a 514-nmargon
laser line for excitation, and the photomultiplier detector was
set to collect emission bandwidth at 526–569 nm.Visualization
of red fluorescent protein was achieved using a 560-nm diode
laser for excitation, and the photomultiplier detector was set to
collect emission bandwidth at 565–621 nm.
AGB1 and ARD1 Mutagenesis—The coding sequences of
AGB1 and ARD1 were mutagenized using the QuikChange
Multi andQuikChange Lightning Site-directedMutagenesisTM
kits, respectively (Agilent Technologies, Santa Clara, CA).
Mutagenesis primers were designed using the QuikChange
primer design program.Mutationswere confirmedby sequenc-
ing and were expressed and purified as described above.
Inductively Coupled Plasma-Mass Spectroscopy—Measure-
ments were performed in theMass Spectrometry Facility of the
Department of Chemistry, University of North Carolina,
Chapel Hill, using a Varian 820 inductively coupled plasma-MS
(Palo Alto, CA), now part of Bruker Daltonics (Billerica, MA).
Protein samples were prepared by adding 1ml of 70%HNO3 to
40 g of protein (sample 1) and 24 g of protein (sample 2) for
10 h. Each samplewas then dilutedwith 2%HNO3 solution to
a final volume of 10 ml. All solutions were made with 18 meg-
ohms of deionized water. A 5 ppb indium solution (in 2%
HNO3)was used as the instrument internal standard during the
runs. Isotopes 24Mg, 55Mn, 57Fe, 59Co, and 60Ni were quantita-
tively monitored in a peak hopping mode with a total of 100
scans per point per isotope (50,000 s of dwell time and five
replicates of 20 scans).
Carbon Monoxide Assay—The carbon monoxide (CO) assay
was performed according to Sundin and Larsson (20). The for-
mation of CO was monitored and quantified using a Hewlett-
Packard 6890 gas chromatograph equipped with an Agilent
G2747Anickel catalyst systemwith a flame ionization detector.
The injector temperature was set at 60 °C, the oven tempera-
ture at 35 °C, the nickel catalyst temperature at 375 °C, and the
detector temperature at 250 °C. The enzyme-catalyzed solution
was placed in a gas tight sealed vial with 1 ml of CO liberating
solution (7.5 g of saponin in 1M sulfuric acid). This vial was then
vortexed for 1 min and shaken for 40 min at 250 rpm at 37 °C.
An aliquot of 100 l from the headspace gas phase was injected
with a gas-tight syringe into the inlet of the GC column.
Enzymatic Assay—The enzymatic assays to probe for activity
of ARD1 and mutant proteins were performed according to
Zhang et al. (21) with some modifications. All experiments
were performed in three consecutive steps in an anaerobic
cuvette. First, the substrate acireductone was built to the final
concentration of about 125 M by 75 nM E1 enzyme and in the
presence of 200 g/ml catalase. The buffer saturated with
molecular oxygen (280 mM) was then added, and the rate of
acireductone decay was measured at 308 nm. The average oxy-
gen-induced decay rate was 8.5  1011  1.5  1011 mol of
substrate/s. This rate was accounted for in the calculations of
the initial rates of the enzymes. Finally, a controlled amount
of ARD1 variant was added, and the depletion of acireductone
wasmonitored at 308 nm for at least 300 s. The initial rateswere
calculated by selecting the linear portion of the graph and cal-
culating the linear fit in this region.
RESULTS
Overexpression of the Coding Region of At4g14716 (Formally
SGB3) Suppresses the agb1-2 Etiolated Phenotype—To identify
dominant mutations that suppress a null (agb1-2) phenotype,
agb1-2 seeds were transformed with a transcriptional enhancer
element from the cauliflower mosaic virus 35S promoter that
was randomly inserted into the genome. The resulting trans-
genic population was screened for genes whose overexpression
suppressed the shortened hypocotyls and open apical hook
present in 2-day-old, etiolated agb1-2 seedlings (Fig. 1,A andB)
(4, 13). Eight genetic loci suppressed this phenotype to varying
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degrees, and these loci were named Suppressor of G Beta 1–8.
The suppressor screen and one of the resulting genetic suppres-
sors, SGB1, was described previously (9). This study focuses on
SGB3, which fully rescued the hypocotyl length phenotype and
partially rescued the apical hook opening phenotype. The
genomic fragment containing the enhancer was isolated by
plasmid rescue, and the genetic position of the enhancer was
determined by sequencing. Because the 35S enhancer can stim-
ulate expression of genes within a 10-kb range (5 kb in each
direction of the enhancer insertion position) (13), the transcript
levels of the four adjacent genes (within the 10-kb region
surrounding the enhancer) were tested to determine which
genes had higher expression levels due to the enhancer (Fig.
1C). The only gene displaying an elevatedmRNA transcript was
At4g14716 (Arabidopsis Genome Initiative accession). To
show that increased expression of At4g14716 was responsible
FIGURE 1. sgb3-1D is a genetic suppressor of agb1-2. A, 2-day-old etiolated phenotype of wild type, agb1-2, and sgb3-1D/agb1-2 seedlings. Bar, 1 mm.
B, quantification of the hypocotyl lengths and apical hook angles observed in A. Error bars, standard error. C, enhancer locus identification and confirmation of
enhanced SGB3 transcript levels by RT-PCR. PCR products were run on two separate gels in nonadjacent lanes. Predicted functions of the proteins encoded by
each gene are indicated below the gene name. D, recapitulation of the sgb3-1D/agb1-2 phenotype by overexpressing SGB3 in the presence and absence of
AGB1. E, methionine salvage pathway as defined by experiments in bacterial and plant systems (28, 41). AdoMet is recycled into methionine via the interme-
diates MTA, 5-methylthioribose (MTR), and acireductone. Ni-ARD catalyzes an off-pathway reaction, although Fe-ARD catalyzes an on-pathway reaction and
promotes the recycling of methionine. Characterized enzymes are indicated in red (SAMS, AdoMet synthase; MTN, MTA nucleosidase; MTK, MTA kinase; E1, E1
enolase/phosphatase). Ethylene is produced from AdoMet via 1-aminocyclopropane-1-carboxylate (ACC) by 1-aminocyclopropane-1-carboxylate synthase
(ACS), and 1-aminocyclopropane-1-carboxylate oxidase (ACO). AdoMet is also decarboxylated (dSAM) and facilitates the synthesis of the polyamines spermi-
dine (Spd, via Spd synthases, SPDS) and spermine (Spm, via Spm synthases, SPMS) from putrescin (Put).
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for the rescued agb1-2 phenotype that was observed in the
enhancer population, we ectopically expressed the coding
region of At4g14716 under the control of the strong 35S pro-
moter into both agb1-2 and wild type backgrounds. As shown
in Fig. 1D, overexpression and ectopic expression of the
At4g14716 coding region rescued the etiolated hook and hypo-
cotyl phenotypes observed in agb1-2 seedlings. To determine
whether any other phenotypes were rescued by the ectopic
overexpression of At4g14716 in agb1-2 plants, SI wasmeasured
in 7-day-old seedlings. Although the SI in agb1-2 is significantly
higher than that of Col-0 plants (22), overexpression of
At4g14716 in agb1-2 rescued the wild type phenotype (supple-
mental Fig. S1A). The overexpression of the At4g14716 coding
region in the presence ofAGB1 (wild type plants) did not affect
the 2-day-old etiolated apical hook opening or hypocotyl length
(quantified in supplemental Fig. S1B), indicating that the
At4g14716 overexpression phenotype requires the loss of
AGB1. These data show that AGB1 and At4g14716 interact
genetically to control hypocotyl length and apical hook
opening.
At4g14716 Encodes ARD1, an Acireductone Dioxygenase—A
BLAST analysis revealed that SGB3 encodes a gene previously
annotated as ARD1, an acireductone dioxygenase-like protein.
ARD1 has high similarity to previously identified eukaryotic
acireductone dioxygenase proteins (supplemental Fig. S2A).
ARD1 is 79% identical and 92% similar to Oryza sativa (rice)
ARD1 (OsARD1, e value  4.0  1091) and 63% identical and
77% similar to Mus musculus (mouse) ARD (MmADI1, e
value 5.0 1065). ARD1 is 28% identical and 49% similar to
a prokaryotic ARD from the bacterium Klebsiella oxytosa
(KoARD, e value  1.0  107). There are two available ARD
atomic structures, one of KoARD and one of MmADI1. Based
on the higher sequence similarity between ARD1 and
MmADI1, we utilized the MmADI1 crystal structure (PDB
code 1VR3) (23) as a template and threaded ARD1 onto it to
generate a homologymodel (supplemental Fig. S2B). The struc-
ture was robust (homology score  0.74), and as shown in sup-
plemental Fig. S2B, most of the surface and active site residues
were conserved between plants and mammals (pink residues).
Additionally, the three histidine residues and one glutamic acid
required for metal binding in the ARD1 active site (24) were
fully conserved (supplemental Fig. S2B, dark blue residues).
The enzymatic activity of ARD proteins was previously char-
acterized in bacteria, plants, and mammals. ARD catalyzes a
committed step in themethionine salvage pathway,which recy-
cles methionine from S-adenosylmethionine (AdoMet) (Fig.
1E) (25). This pathway is important in that it provides the orga-
nism with a source of methionine under limiting conditions,
regulates the production of polyamines, and in plants allows for
the production of ethylene (26). KoARD proteins catalyze two
distinct reactions dependent upon which divalent metal ion is
bound in the active site (27, 28). Fe-bound ARD catalyzes the
on-pathway reaction that converts acireductone to the keto
acid -keto--methylthiobutyrate (the methionine precursor).
Ni-ARD catalyzes an off-pathway reaction whose products are
-(methylthio)propionate, carbonmonoxide, and formate (29).
The different ARD activities are measured in vitro by monitor-
ing the accumulation of CO (off-pathway) or keto acid (on-
pathway) (30–32).
ARD1 Function in Vivo—ARD1 tDNA insertion mutants
were obtained to determine the loss-of-function, hypocotyl
phenotype. The mRNA transcript levels were determined by
RT-PCR (Fig. 2A). Two of the three ARD1 alleles, ard1-1 and
ard1-3, were transcript-null. ard1-2 likely created a truncated
transcript because the RT-PCR results detected the presence of
a fragment upstream of the tDNA insertion site, but no full-
length productwas present (Fig. 2A, reactionsCD andAD,
respectively). Two-day-old etiolated seedlings lacking a func-
tional ARD1 transcript mimicked the agb1-2 phenotype in that
they had short hypocotyls, and they showed an apical hook
opening that was intermediate to agb1-2 and wild type plants
(Fig. 2B). We compared the estimated number of epidermal
cells in the 2-day-old etiolated seedlings and found that ard1-1,
like agb1-2, contained fewer cells (10 and 9 cells, respec-
tively) than wild type plants (20 cells). agb1-2 plants overex-
pressing ARD1 (Fig. 1D, agb1-2  35S::SGB3) contained the
wild type number of cells (data not shown); this indicates that
ARD1 overexpression rescues the agb1-2 hypocotyl length phe-
notype by restoring cell division.
These results prompted the hypothesis that AGB1 regulates
ARD1 activity to control cell division. Regulation could occur at
different levels, for example, by control of ARD1 subcellular
location or by direct control of ARD1 catalytic properties. To
test the former, the localization of ARD1-GFP was determined
in both the wild type and agb1-2 backgrounds, and no major
difference in patterns was detected using transient co-expres-
sion in protoplasts (supplemental Fig. S3A).
One of the products of the methionine salvage pathway in
plants is the gaseous hormone ethylene (Fig. 1E). When etio-
lated seedlings are grown in the presence of ethylene, they dis-
play a set of phenotypes called the triple response, shorter
hypocotyls, exaggerated closure of the apical hook, and radially
expanded hypocotyls (8). The steady-state level of ethylene in
agb1 and ard1mutant seedlings was determined because of the
following: 1) ARD1 may operate in the methionine salvage
pathway based on its homology with known ARD proteins
(supplemental Fig. S2); 2) AGB1 positively regulates ARD1
genetically, and 3) 2-day-old etiolated agb1-2 and ard1mutants
display some aspects of the triple response. ard1 null mutants
display one triple response trait (short hypocotyls), leading to
the prediction that ethylene levels in ard1mutants may be ele-
vated. Conversely, another ard1 triple response trait (open
hooks) leading to the prediction that ethylene levels are lower
than wild type seedlings. The steady-state level of ethylene in
2-day-old etiolated seedlings was slightly reduced in agb1-2,
ard1-1, ard1-2, and ard1-3 compared with wild type (Fig. 2C).
These data correlatewith the 2-day-old apical hook phenotypes
of these plants (Fig. 2D).
ARD1 Physically Interacts with AGB1—We showed that
ARD1 genetically interacts with AGB1 because ARD1 overex-
pression rescues the agb1-2 etiolation phenotype (Fig. 1). To
test for physical interaction, Y3Hgenetic complementationwas
performed. To confirm that each construct could be expressed
in yeast cells, single transformants were grown on an appropri-
ate nutritional dropout medium (leucine for ARD1 and
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tryptophan for AGB1) (Fig. 3A). ARD1 was expressed in
AH109 yeast cells in the presence or absence of the AGB1-
AGG1 heterodimer. When grown on nutritional media select-
ing for a positive interaction between the three proteins
(histidine), only yeast cells containing both AGB1-AGG1 and
ARD1 were able to grow (Fig. 3A). Yeast containing AGB1-
AGG1 alone or ARD1 alone failed to grow, indicating that nei-
ther construct alone was responsible for the growth observed
on histidine media. These data suggest that ARD1 physically
interacts with the AGB1-AGG1 heterodimer.
To test the validation of the Y3H results, we determined if
recombinant ARD1 protein interacted with the AGB1-AGG1
heterodimer using co-purification via an affinity pulldown
assay. Lysed bacterial cells expressing aGST-taggedARD1 pro-
tein were incubated with glutathione beads, and after washing
the ARD1-bead complexes, purified AGB1-AGG1 protein was
added. The protein complexes were eluted from the beads and
were subjected to SDS-PAGE. A polyclonal anti-AGB1 raised
against an AGB1 peptide from the N-terminal helix of AGB1
was used (see “Experimental Procedures” and supplemental
Fig. S3B) to detect the proteins by immunoblot analysis. As seen
in Fig. 3B, AGB1 was pulled down with ARD1, corroborating
the Y3H data and showing that these proteins interact physi-
cally in vitro. However, a separate GST fusion protein (ARD4-
GST) did not pull down AGB1, indicating that ARD1, and not
GST, was responsible for this positive interaction.
To determine whether these proteins interact physically in
vivo, we utilized BiFC. Each bait and prey combination (ARD1
versusAGB1,ARD1, orAHP2)was cloned into vectors contain-
ing either the C- or N-terminal half of YFP, and all combina-
tions were expressed inNicotiana benthamiana leaf epidermal
cells. A positive interaction was scored by the reconstitution of
FIGURE 2. ARD1 and AGB1 share etiolated hypocotyl phenotypes. A, location of three tDNA insertions in ARD1. Arrows indicate genotyping primers used to
amplify the mRNA transcript. RT-PCR was performed using the primers indicated. Actin2 was used as a reference transcript. PCR products were run on two
separate gels in nonadjacent lanes. B, hypocotyl lengths and apical hook angles of 2-day-old etiolated seedlings. *, p  0.05; **, p  0.005; ***, p  0.0005.
Results were an average of two independent experiments and are representative of three additional experiments performed. Error bars, means  S.E.
C, ethylene biosynthesis of wild type and ard1 or agb1 mutant plants grown in the dark for 2 days. Each measurement is an average of at least three vials, and
the experiments were repeated with similar results. *, p  0.05; **, p  0.005. Error bars, means  S.E. D, etiolated phenotype of 2-day-old seedlings. Bar, 1 mm.
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YFP fluorescence as visualized under scanning confocal
microscopy. ARD1 was able to reconstitute the fluorescent sig-
nal withAGB1, confirming the positive interaction between the
two proteins (Fig. 3C, top panel). Additionally, ARD1 was con-
firmed to form a homodimer or oligomer, which was shown for
the rice proteinOsARD1 (31). As a negative control, we showed
thatARD1does not interactwith a cytokinin-pathway cytosolic
protein AHP2 (Fig. 3C, bottom panel).
ARD1 Has Acireductone Dioxygenase Enzymatic Activity
That Is Stimulated by AGB1—RecombinantHis6-taggedARD1
was purified to perform enzymatic assays. To determine which
metal ormetalswere bound in the active site, ARD1proteinwas
analyzed using inductively coupled plasma mass spectrometry
(Table 1). ARD in the on-pathway binds Fe2 orMg2, whereas
ARD in the off-pathway binds Ni2, Co2, or Mn2 (29).
Therefore, we assayed for the presence of each of the five diva-
lent metal ions. Fe(II) constituted 80% of the metal ions in the
protein sample. The remaining ions in the sample were Mg2
(13%), Co2 (5%), and Ni2 (2%). Together, these data suggest
that ARD1 primarily performs the on-pathway reaction and
that the purified ARD1 displayed 100% metal occupancy. The
equal molar concentration of Fe2 and ARD1 indicate this
metal is iron.
A polyhistidine-tagged ARD1 protein was used to measure
the enzymatic activitywith acireductone. Because acireductone
is short lived and reactive with atmospheric oxygen, the reac-
tionwas performed anaerobically, and acireductone was gener-
ated in situ immediately prior to the addition of ARD1 using a
previously published protocol (21). ARD1 depleted the acire-
ductone substrate, but no CO production was observed as
detected by gas chromatography, suggesting that ARD1 does
not significantly catalyze the off-pathway reaction. Although
significant enzymatic activity was observed with a freshly pre-
pared sample of ARD1 (Fig. 4,A,white squares, andB), its activ-
ity decreased over time, making it difficult to kinetically char-
acterize the enzyme. After 7 days at 4 °C, all activity was lost; if
the enzyme was stored at 20 °C, the observed rates were 50%
or less than the originally recorded numbers. Because of these
factors, all rate comparison assays were performed on the same
day and with the same batch of ARD1 that was used as a
reference.
Because ARD1 and AGB1 interact physically (Fig. 3), we
tested whether AGB1 directly affected ARD1 enzymatic activ-
ity. We performed the same assay described above in the pres-
ence or absence of purified AGB1-AGG1 protein. In multiple
experiments and independently of the ARD1 batch or the day
on which the experiment was performed after its purification,
AGB1-AGG1 consistently stimulated ARD1 activity about
2-fold when mixed in a 1:1 ARD1/AGB1-AGG1 molar ratio
(Fig. 4, A, black squares versus open squares, and B). The error
FIGURE 3. AGB1 and ARD1 interact physically. A, growth of yeast strain AH109 containing the proteins indicated (AGB1-AGG1 (AtG) alone or AtG 
ARD1) on yeast dropout media missing leucine, tryptophan, and histidine. This selects for a positive interaction between each of the two genes, resulting in no
growth for the strain containing AtG alone and positive growth for the strains containing both AtG and ARD1. Four independent colonies were cultured
on the triple dropout media to confirm the interaction. Positive growth on media lacking leucine or tryptophan confirms the presence of ARD1 or AtG,
respectively. B, His6-tagged G was pulled down with ARD1-GST on a glutathione resin and detected by immunoblotting (IB) with anti-AGB1. G was not
pulled down with ARD4-GST. Proteins were separated on one gel in nonadjacent lanes. IP, immunoprecipitation. C, bimolecular fluorescence complementa-
tion in N. benthamiana leaf epidermal cells (error bar, 20 M). ARD1 interacts with AGB1 and homodimerizes. ARD1 does not interact with cytosolic protein AHP2
(negative control, merged panel includes differential interference contrast image to show the cell borders). Mitochondrial red fluorescent protein expression
(mCherry) confirms positive transformation of all cells.
TABLE 1
Quantification of metals bound to ARD1
An inductively coupled plasma-mass spectrometry analysis was utilized to detect
the presence of 24Mg, 55Mn, 57Fe, 59Co, and 60Ni. Elemental concentration is

















G Regulates ARD1 Activity
AUGUST 26, 2011 • VOLUME 286 • NUMBER 34 JOURNAL OF BIOLOGICAL CHEMISTRY 30113
was estimated based on the maximum error calculated in
similar experiments. Although these experiments were
repeated several times, the instability of the enzyme and
therefore the difference in initial rates from experiments
performed on different days or with different preparations of
enzymes made it impossible to directly compare rates from
different experiments.
To determine the extent to which AGB1-AGG1 stimulates
ARD1 enzymatic activity, we measured ARD1 activity in the
absence or presence of increasing concentrations of AGB1-
FIGURE 4. AGB1-AGG1 stimulates ARD1, and this stimulation is reduced in several AGB1 mutants. A, ARD1 enzymatic activity in the presence and absence
of wild type AGB1-AGG1 (G) and various AGB1 mutants in a 1:1 molar ratio. B, enzymatic rates of ARD1 activity in the presence of each AGB1-AGG1 wild type
or mutant construct indicated (none indicates ARD1 alone). The rates are expressed in moles of substrate/mol of enzyme/s  S.E. and were recorded as initial
rates. These rates account for the average oxygen-induced decay rate (base line, see “Experimental Procedures”). C, four views of the AGB1 protein surface. All
colored residues compose a region strictly conserved between plant and mammalian species. Green residues are conserved, but they have no previously known
function and may be required for structural integrity. Magenta residues form the G binding interface. Colored residues indicate point mutations created
(W109A, blue; S129R, yellow; E248K/R25D, orange; Q120R, T188K, R235E, red; colors are consistent with those in A, D, and E). Gray residues are not conserved
between plants and mammals. Black residues are the G protein. D, AGB1 mutant proteins were co-expressed in E. coli with AGG1 and purified via the His tag
on AGG1 by affinity column chromatography (immunoblot, anti-AGB1). Proteins were separated on one gel in nonadjacent lanes. E, Y3H growth of strains
containing ARD1 in the presence or absence of wild type and mutant AGB1 proteins. Cells expressing the genes encoding mutant AGB1 proteins were able to
grow on media lacking histidine, indicating that the mutations do not disrupt the physical interaction between AGB1 and ARD1.
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AGG1. The activity of ARD1 increased with an increasing
molar ratio of AGB1-AGG1/ARD1 (supplemental Fig. S4A)
andwas so rapid that an initial rate could not be calculated once
themolar ratio exceeded 2:1 (supplemental Fig. S4B). This level
of stimulation is in the same range (3–6-fold) as the stimulation
of the effector PLC-2 that was previously reported (33).
Identification of a Potential AGB1-ARD1 Interface—To fur-
ther characterize the interaction between AGB1 and ARD1, we
sought to identify key residues that could form critical contacts
at an interface between the twoproteins. Because neitherAGB1
norARD1was crystallized alone or in complex, an evolutionary
approach to predict binding regions between the two was nec-
essary. For this analysis, our previously published prediction of
novel G interfaces based on the evolutionary history of G
proteins was used (33). We identified surface regions of the
AGB1 structure that are invariant between plants and mam-
mals. This region was reduced by culling residues that formed a
hydrogen bond with either the polypeptide backbone or with
G (which is required to stabilize G) because some conserved
surface residues are critical for structural maintenance,
although others are required for protein-protein interactions
that first evolved in plants and are maintained throughout
eukaryotic evolution (see “plant ancestor” of Fig. 4A of Ref. 33).
Rather, residues with solvent-exposed functionality were
assumed to be available for protein-protein interactions. Based
on these criteria, a limited number of residueswere chosen, and
four sets of correspondingmutant AGB1 proteins were created
as follows: the single mutations W109A and S129R, the double
mutant E248K/R25D, and the triple mutant Q120R/T188K/
R235E (Fig. 4C). Trp-109 and Ser-129 are both located in the
conserved surface that is known from mammalian studies to
bind G (33, 34). Additionally, Trp-109 is an interaction “hot
spot” in mammalian proteins and is critical for interaction of
G with not only G but PLC-2, AC2, and cation channels
(34). The remaining two regions had no previously identified
functions in mammals and thus represented key contacts of
potential interaction interfaces with ARD1 (an interaction
identified in plants but not yet identified in mammals). Mutant
proteins were co-expressed with AGG1 (G) containing a His
tag for affinity purification and a mutated CAAX box for
improved solubility. The AGB1-AGG1 heterodimer was puri-
fied from Hi5 insect cells by affinity column chromatography.
The His-tagged AGG1 selected AGB1-AGG1 dimers (Fig. 4D)
ensuring that the mutant AGB1 proteins were properly folded,
as their interaction with AGG1 was necessary for purification.
In addition, the mutant proteins physically interacted with
ARD1 in a Y3H assay (Fig. 4E) indicating that themutant AGB1
proteins were still able to at least weakly bind to ARD1.
The mutated AGB1-AGG1 dimers were tested for their abil-
ity to activate ARD1 in vitro. The mutant S129R fully activated
ARD1 to the same or a greater level than wild type AGB1-
AGG1, suggesting that Ser-129 is not critical for stimulation or
that the S129R mutation confers a slight enhancement of
AGB1-AGG1 stimulation of ARD1. The mutants W109A,
E248K/R25D, and Q120R/T188K/R235E abolished ARD1
stimulation, suggesting that these residues form critical con-
tacts for ARD1 stimulation (Fig. 4, A and B). Together, these
data suggest that these three groups of residues are required for
AGB1-AGG1 to stimulate ARD1 enzymatic activity. These
results suggest that AGB1-AGG1, and not an Sf9 G contam-
inant that was not detected by anti-AGB1 (see supplemental
Fig. S3B for lack of reactivity between uninfected Sf9 cells and
anti-AGB1), was responsible for this stimulation; because wild
type and mutant AGB1 constructs were purified together, the
lack of stimulation in some AGB1 mutants confirms that the
stimulation by the remaining constructs was not due to
contamination.
ARD1 Activation Mechanism—From the modeled ARD1
structure (supplemental Fig. S2), we predicted that a region of
ARD1 would interact with G and move in response to its
binding, changing the accessibility of the ARD1 active site (Fig.
5A). The C-terminal -helix (-5) and preceding loop of ARD1
partially block the opening of the active site occupied by the
metal ion. This obstruction likely lowers basal ARD1 activity,
and by displacement of this helix and/or loop, G may stimu-
late ARD1 activity. In addition, a conserved tryptophan residue
exists in the middle of the loop, and it is likely involved in the
activationmechanism.To test the proposedmechanismof acti-
vation, we created and purified three versions of mutant ARD1
protein. One protein contained an alanine instead of the con-
served tryptophan (W166A). The remaining proteins con-
tained either a deletion of the C-terminal portion of -5 (188)
or a deletion of all of -5 and a portion of the preceding loop
(175). In the absence of AGB1-AGG1 protein, only the
W166A mutant had higher enzymatic activity than wild type
ARD1 (Fig. 5, B and C). However, when AGB1-AGG1 was
added to the reaction, neitherW166A nor175 was stimulated
by AGB1-AGG1 as seen in wild type and in 188. These data
suggest that Trp-166 represses the enzymatic activity of ARD1
and that Trp-166 and the region between residues 175 and 188
are required for stimulation by AGB1-AGG1. The C-terminal
portion of 5 was not required for stimulation by AGB1-AGG1
and did not negatively regulate ARD1 enzymatic activity.
DISCUSSION
AGB1 physically interacts with ARD1 to stimulate catalytic
activity. Several lines of evidence support direct interaction and
regulation, including site-directedmutagenesis to map roughly
the protein-protein interface. The region of G that stimu-
lates ARD1 activity is conserved between plants andmammals,
raising the possibility that the activation mechanism is ancient.
ARD proteins are present in bacterial species although het-
erotrimeric G protein components are not. How is it possible
that G proteins stimulate ARD enzymatic activity in
eukaryotes but that this stimulation is not required for prokary-
otic activity? To answer this question, we created a model pre-
dicting the molecular mechanism of activation of ARD1 by
AGB1-AGG1 (Fig. 5). The three ARD1 binding regions on
AGB1 are spread throughout one surface as shown in the top
left panel of Fig. 4C, and the surface area is large enough that
binding to the whole region would require a conformational
change of ARD1. Upon examination of the modeled structure
of ARD1 (supplemental Fig. S2) and of its parent structure
(mADI1, PDB code 1VR3 (23)), we noticed several features that
would allow such an interaction to occur. First, the C-terminal
-5 helix ofARD1 and the loopdirectly preceding it pack tightly
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against the opening to the pocket that the metal ion and sub-
strate occupy, thus obscuring the opening.Wepropose that this
packing creates a low basal activity of ARD1. Binding of AGB1-
AGG1 would displace the helix and loop, opening the ARD1
pocket to promote faster substrate/productmovement into and
out of the active site. Furthermore, we propose that the large
hydrophobic tryptophan residue in the middle of the loop reg-
ulates this movement.
We tested these predictions by creating two truncation
mutations (175 and 188) and one substitution mutation
(W166A). The higher basal activity of W166A indicates that
Trp-166 restricts the basal enzymatic activity of ARD1. How-
ever, it is also a critical point of regulation by AGB1-AGG1, as
AGB1-AGG1was unable to further stimulate thismutated pro-
tein. The portion of the loop and-5 helix between residues 175
and 188 did not restrict basal ARD1 activity but was critical for
stimulation by AGB1-AGG1 (the C terminus of -5 was not
involved in this process). Therefore, we suggest that Trp-166
serves as a latch that maintains ARD1 in a state of low basal
enzymatic activity (designated inactive state). Upon binding by
AGB1-AGG1, this latch is unlocked, and the enzyme activity is
stimulated. AGB1-AGG1 utilizes both Trp-166 and at least a
subset of the residues 175–188 to achieve this stimulation.
These predictions are supported by several structural obser-
vations. First, although the crystallized mammalian structure
was in the inactive conformation, with the loop and C-terminal
helix obscuring the pocket, the Ni-ARD bacterial structure
(PDB code 1ZRR (35)) showed a displaced loop and helix and a
much more accessible pocket, and the Fe-ARD bacterial struc-
ture (PDB code 2HJI (28)) showed a disordered C terminus that
indicates mobility of the C-terminal loop and helix. Thus, the
structural differences observed agree with our proposed
method of stimulation; because the bacterial structures exist in
a more active state, their only regulation may be from the diva-
lent metal-bound active site. However, the inactive state of the
eukaryotic protein suggests the need for regulation in this case
by G.
The best understood function of ARD proteins is to operate
in the methionine salvage pathway, utilizing one of two classes
of divalentmetal ions to affect the structure and thus to convert
acireductone into either amethionine precursor or an off-path-
way product. The high sequence similarity between ARD1 and
FIGURE 5. Mechanism of ARD1 stimulation by AGB1. A, structural model of ARD1 derived from two crystal structures (MmADI1, PDB code 1VR3; KoARD, PDB
code 1ZRR) depicting the proposed mechanism of stimulation by AGB1-AGG1. Green sphere represents the bound metal ion in the active site. Left structure is
1VR3, with truncated and mutated regions indicated in magenta, green, and cyan. Right structure is a chimera of 1VR3 and 1ZRR; navy residues were derived from
1VR3, and orange loop and green/cyan helix were derived from 1ZRR. The location of the C-terminal loop and helix indicates the inactive and active conforma-
tions of the protein. The three mutations made on ARD1 are indicated in the structure. B, enzyme activity of wild type versus mutant ARD1 in the presence or
absence of wild type AGB1-AGG1 (G). The final enzyme concentration was adjusted to 24 nM, and the substrate was built up to about 125 M in all cases. The
molar ratio of ARD1/G was 0.65:1. C, enzymatic rates of ARD1 wild type and mutants in the presence or absence of wild type G as indicated in B. The rates
are expressed in moles of substrate/mol of enzyme/s  S.D. and were recorded as initial rates on the 3rd day after purification. wtG indicates the rate for
the enzyme alone, and wtG indicates the rate of the enzyme with the addition of wild type G. These rates account for the average oxygen-induced decay
rate (base line, see “Experimental Procedures”).
G Regulates ARD1 Activity
30116 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286 • NUMBER 34 • AUGUST 26, 2011
the previously characterized KoARD and MmADI1 within the
regions required for enzymatic activity (supplemental Fig. S5A)
suggested that ARD1might function in the methionine salvage
pathway, and our results confirmed this prediction. However, it
is also known thatmammalian ARD enzymes aremoonlighting
proteins (36), performing diverse functions in addition to (and
independently of) the enzymatic activity. For example, human
ARD (hADI1) serves as a cancer suppressor in prostate cells.
When its levels were increased in tumor cells, hADI1was found
to induce programmed cell death independent of its enzymatic
function (37). hADI1 has also been shown tomove between the
cytoplasm and nucleus via an undefined nuclear localization
signal and a noncanonical nuclear export signal. One of its
nuclear functions is to facilitatemRNA splicing; this function is
also independent ofmethionine salvage enzymatic activity (38).
ard1nullmutants have shorter hypocotyls thanwild type due
to fewer cells but the reason is unresolved. This may involve
intermediates of the methionine pathway or some other func-
tion of ARD1 (discussed below). The methionine salvage path-
way recovers the thiomethyl group of methylthioadenosine
(MTA, Fig. 1E), a by-product of polyamine biosynthesis, and it
has been shown that polyamines are critical for cell division and
cell cycle maintenance (39). In addition, MTA, a by-product of
the methionine salvage cycle, inhibits polyamine synthesis via
spermine and spermidine synthases (40). Previous studies
showed that mutants of several methionine salvage pathway
components displayed altered polyamine levels (41, 42). There-
fore, it is possible that a decrease in the polyamine pool contrib-
utes to the reduced cell division observed in ard1 and agb1-2
hypocotyls.
Another hallmark of 2-day-old etiolated seedlings is a closed
apical hook; this phenotype protects the apical meristem from
damage as the seedling grows through the soil, and ethylene
production contributes to the maintenance of the hook (8).
Because 2-day-old etiolated ard1 and agb1-2 seedlings display
an opened apical hook, we speculate that the decrease in ethyl-
ene production in these mutants may contribute to this tissue-
specific phenotype. It is important to note that the decrease in
ethylene production measured at this developmental stage
is, although statistically significant, quite small (15–25%),
although we are aware that such a small change in ethylene has
been correlated to a significant alteration in hypocotyl length
(43).
Arabidopsis and other plants (but no nonplant organisms)
contain multiple ARD proteins; the Arabidopsis genome
encodes AtARD1–4. AtARD1 is 96% identical to AtARD2 and
80% identical to AtARD3 but only 67% identical to AtARD4.
These Arabidopsis ARD orthologs are more similar to ARD
proteins from rice than to ARDs from nonplant species, but the
ARD1, ARD2, and ARD3 of different plants are more closely
related to each other (between species) than to the ARD4 of
their own species (supplemental Fig. S5B). Each of the four
ArabidopsisARDproteins can interact withG in vitro and in
vivo (supplemental Fig. S6); G protein signalingmay also utilize
these ARD paralogs.
Although there is a high degree of similarity between ARD1,
-2, and -3, ARD4 is divergent, and we speculate it could possess
a different subset of functions than the other three. The dupli-
cation of ARD proteins in plants is of particular interest in that
it occurred after the divergence of plants from the ancestral
lineage but did not occur in any other family. Additionally,
ARD1 likely diverged from ARD4 before the divergence of rice
and Arabidopsis and then duplicated twice to yield ARD1,
ARD2, and ARD3 after the split (supplemental Fig. S5B). This
pattern and lack of subsequent divergence indicates a func-
tional necessity for multiple ARD family members. Although
plant ARD proteins display conserved metal-binding residues,
suggesting enzymatic activity, Arabidopsis ARD proteins also
possess the conserved noncanonical nuclear export signal iden-
tified in the mammalian ARD proteins (supplemental Fig. S2B,
underlined region), suggesting a nuclear role as well.
It is still not yet clear what other processes ARD proteins
might regulate in plants and which (if any) of these additional
functions are also regulated by G protein signaling. We identi-
fied a role of ARD1 in cell division and that role depends on the
ability of AGB1 to stimulate ARD1 enzymatic activity. Here,
one clear picture of regulation of ARD1 activity by AGB1
emerges, but other functions and mechanisms may follow.
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